Positive data narrow odds on Veracyte’s lung cancer Dx bet
This article was originally published in Clinica
Executive Summary
Newly published data supporting Veracyte’s Percepta bronchial genomic classifier lung cancer test might help position it as a go-to non-invasive assay, just as millions more patients are becoming eligible for routine lung-cancer screening with computer tomography.